Larona 30 mg želučanootporne kapsule
| Name | Larona 30 mg želučanootporne kapsule |
|---|---|
| Former Name | Larona 30 mg kapsule |
| Marketing Authorisation Number | HR-H-895950686 |
| Active Substance | lanzoprazol |
| Composition | jedna kapsula sadrži 30 mg lanzoprazola |
| Pharmaceutical Form | želučanootporna kapsula, tvrda |
| Manufacturer | Jadran Galenski laboratorij d.d., Rijeka, Hrvatska Teva Pharma S.L.U., Zaragoza, Španjolska |
| Marketing Authorisation Holder | Jadran Galenski laboratorij d.d., Svilno 20, Rijeka, Hrvatska |
| Marketing Authorisation Date | 08.11.2017 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/34 |
| Registration Number | 381-12-01/30-17-05 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A02BC03 |
| Marketing status | nije stavljeno u promet |
| SmPC | download |
| PL | download |
